AI assistant
Sending…
MiNK Therapeutics, Inc. — Director's Dealing 2021
Oct 21, 2021
34471_dirs_2021-10-20_0d239b4d-ae49-496c-9ff4-60ed2275afcc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MiNK Therapeutics, Inc. (INKT)
CIK: 0001840229
Period of Report: 2021-10-13
Reporting Person: FLAMENBAUM WALTER MD (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.01 | 2029-11-14 | Common Stock (166980) | Direct | |
| Stock Option (Right to Buy) | $0.01 | 2030-01-30 | Common Stock (139150) | Direct | |
| Stock Option (Right to Buy) | $3.03 | 2031-02-11 | Common Stock (41745) | Direct |
Footnotes
F1: The vesting of all such options was accelerated on March 31, 2021 and were fully-vested as of such date.
More from MiNK Therapeutics, Inc.
Interim / Quarterly Report
2026
May 15
Earnings Release
2026
May 15
Annual Report
2026
Mar 31
Earnings Release
2026
Mar 31
Regulatory Filings
2026
Mar 27
Board/Management Information
2026
Mar 19
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Jan 14
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6